Career:

• Bar admission: 2000
• Graduated from ESCP Europe Business School and holds a Masters in Business Law and Taxation from the University of Paris II Panthéon-Assas
• Partner at Reed Smith LLP
• Partner at ADVANT Altana since 2010 and member of ADVANT steering committee with Advant Nctm and Advant Beiten’s representatives.

Areas of expertise:

• Mergers & Acquisitions, Joint Venture, Company Law, Stock Exchange Law
• Particular focus on cross-border transactions

Practice Areas:

• specialize in public and private mergers and acquisitions and joint ventures, with a particular focus on private cross-border M&A transactions.
• his expertise includes acquisitions and sales of companies and groups, strategic partnerships and joint venture agreements, takeover bids, disposals of non-core assets, reorganizations of groups and shareholding structures, and corporate governance.
• he has a particular interest in the life sciences, high-tech innovation and renewable energy sectors.

Languages: 

• French
• English
• Spanish

Distinctions:

• Best Lawyers – recognized since 2020 (Biotechnology and Life Sciences Practice | Mergers and Acquisitions Law)
• Chambers Global 2023 – Corporate/M&A : High-end Capability – Tier 6
• Chambers Europe 2023 – Corporate/M&A : High-end Capability – Tier 6
• Legal 500 EMEA 2023 – Industry Focus : Healthcare & Life Sciences – Tier 1
• Legal 500 EMEA 2023 – Mergers & Acquisitions – Tier 4
• Option Droit & Affaires 2022 – M&A : Top Law Firms in France M&A deals up to €200 M – 4 stars
• Le Point/Statista 2023 – Palmarès des Meilleurs cabinets d’avocats – Fusions & Acquisitions – 5 stars
• Décideurs (Leaders League) 2022 – Mergers & Acquisitions : Operations worth between 75 M€ et 500 M€ – Excellent
• Décideurs (Leaders League) 2022 – Santé, Pharma & Biotechnologies : Opérations de Capital Risque – Forte notoriété
• Décideurs (Leaders League) 2022 – Santé, Pharma & Biotechnologies : Opérations de Capital, Joint-Ventures et Corporate  – Forte notoriété

Publications :

• “Fusions-Acquisitions : Les Impacts D’Une Crise Inédite” – Forbes France – April 2020
• “Foreign Direct Investment under Greater European and French Scrutiny” – The American Lawyer – May 2018
• “Shareholder activism in France : a growing threat” [L’activisme actionnarial en France : Une menace grandissante] – The American Lawyer (Focus International, Winter 2017) – Janvier 2017
• “Acquiring a carved out business in France, the usual suspects and the French touch” – The American Lawyer Magazine – Mai 2016
• “FDI: France’s attractiveness is growing again” [Investissements directs étrangers : la France redevient plus attractive] – The American Lawyer Magazine – Octobre 2014
• “BioAlliance Pharma and Topotarget enter into a Cross-Border Merger Agreement” [BioAlliance Pharma et Topotarget réalisent une Fusion Transfrontalière] – Lawyer Monthly – Septembre 2014
• “Fusions transfrontalières de sociétés cotées : quand l’Europe des entreprises devient une réalité” – Option Finance – Septembre 2014
• “The Initial Bond Offering, The future of SMEs financing” – Financier Worldwide – Avril 2013
• “L’IBO, un excellent outil de financement alternatif pour les ETI” – Décideurs – Mars 2013
• “Global M&A / France” – American Lawyer – Janvier 2013
• “Key concepts involved in acquisitions of ailing manufacturing companies in France” – Doing business in France – Edition 2012
• “Réussir ses carve out et transferts d’activités” – CF News – Février 2012
• “Alternext, un marché redynamisé” – Décideurs – Novembre 2010
• “Communiquer sur ses difficultés, un exercice toujours délicat pour les sociétés cotées” – Option Finance – Septembre 2009
• “Advantages Of A Dual Listing On NYSE-Euronext” – Law 360° – Août 2008

Interviews :

• « Les acteurs du M&A doivent préparer l’avenir », L’Agefi, April 2020
• « La gouvernance reste un enjeu central pour les entreprises familiales », l’Agefi, October 2019
• « Au secourts, mon fournisseur veut entret au capital », Les Echos, January 2018
• The American Lawyer, « Keeping M&A afloat in France », janvier 2016
• Option Finance, « Fusion transfrontalière entre Bioalliance Pharma et Topotarget», September 2014
• The American Lawyer, « The French Paradox », February 2014
• The American Lawyer, « France, critical measures », May 2013
• Capital Finance, « Alternext a gagné en intérêt », July 2011

International Conferences:

• February 2017, International Bar Association, Paris: speaker on a panel presentation on “European Share for Share Deals”
• February 2014, International Bar Association, Paris: speaker on a panel presentation on “The colour of money: anti-bribery and M&A”
• October 2013, International Bar Association, Boston: speaker on a panel presentation on “Letters of intent, confidentiality agreements and other pre-contractual agreements”

Associations:

• ESCP Europe Alumni
• International Bar Association
• Institut Français des Administrateurs (French Directors’ Association)